FDA expands setmelanotide indication to patients as young as 2 years
The expanded indication is approved to reduce excess body weight and maintain reduction long-term in children 2 years and up with obesity due to BBS, POMC, or LEPR deficiency.
Food Insecurity and the Dangers of Infant Formula Dilution
Afrezza inhaled insulin meets primary endpoint in phase 3 pediatric diabetes trial
The primary endpoint was non-inferiority in HbA1c levels after 26 weeks.
Demystifying Infant Formula
Healthy prenatal diet could be upstream obesity prevention strategy
"Our findings support the recommendation of a healthy diet based on the current guidelines (as measured by the HEI) during pregnancy, since it may reduce patterns of infant growth outside reference ranges."
Understanding pediatric ED readiness: Quartiles, disparities, and cost
Nathan Kuppermann, MD, MPH, explains the different quartiles of the pediatric emergency department readiness scale, and why the top tier is so crucial for pediatric patients.
